» Articles » PMID: 23660291

Differences in Imaging Characteristics of HPV-positive and HPV-Negative Oropharyngeal Cancers: a Blinded Matched-pair Analysis

Overview
Specialty Neurology
Date 2013 May 11
PMID 23660291
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Human papillomavirus-positive oropharyngeal cancers typically have younger age of onset, limited tobacco exposure, and more favorable prognosis than HPV-negative oropharyngeal cancers. We assessed whether HPV-positive and HPV-negative oropharyngeal cancers have consistent differences in pretreatment imaging characteristics.

Materials And Methods: A retrospective review of 136 pretreatment CT examinations of paired HPV-positive and HPV-negative oropharyngeal cancers matched for T stage, tumor subsite, and smoking status was performed with the reviewing radiologist blinded to HPV status and clinical stage. Demographic/clinical characteristics and imaging characteristics of primary lesions and metastatic nodal disease were compared by use of Fisher exact testing. The McNemar χ(2) test was used for the matched-pair analysis.

Results: By imaging, HPV-negative tumors were more likely to demonstrate invasion of adjacent muscle (26% versus 6%, P = .013). HPV-positive primary tumors were more likely to be enhancing and exophytic with well-defined borders, whereas HPV-negative primary tumors were more likely to be isoattenuated and demonstrate ill-defined borders, though these results were not statistically significant. HPV-positive tumors were more likely to demonstrate cystic nodal metastases than HPV-negative tumors (36% versus 9%, P = .002).

Conclusions: In this matched and blinded analysis of the imaging differences between HPV-positive and HPV-negative oropharyngeal cancers, HPV-positive carcinomas often had primary lesions with well-defined borders and cystic nodal metastases, whereas HPV-negative primaries more often had poorly defined borders and invasion of adjacent muscle.

Citing Articles

Imaging Findings of Human Papillomavirus-Positive and Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma Associated with Recurrence.

Suto T, Kawaguchi M, Kato H, Shibata H, Ogawa T, Ando T J Clin Med. 2025; 14(3).

PMID: 39941703 PMC: 11818298. DOI: 10.3390/jcm14031027.


The radiological features of HPV-positive vs HPV-negative OPSCC at a South African hospital.

Naranbhai A, Afrogheh A, OHagan S, Grobbelaar J, van Rensburg L SA J Radiol. 2024; 28(1):2976.

PMID: 39650704 PMC: 11621980. DOI: 10.4102/sajr.v28i1.2976.


MRI for Differentiation between HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.

Chen L, Lauwers I, Verduijn G, Philippens M, Gahrmann R, Capala M Cancers (Basel). 2024; 16(11).

PMID: 38893224 PMC: 11171338. DOI: 10.3390/cancers16112105.


The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV).

Movahed F, Darzi S, Mahdavi P, Mahdi M, Allela O, Sameer H Virol J. 2024; 21(1):124.

PMID: 38822328 PMC: 11143593. DOI: 10.1186/s12985-024-02397-9.


Oral and periodontal manifestation related during human papilloma virus infections: Update on early prognostic factors.

Amato M, Santonocito S, Bruno M, Polizzi A, Mastroianni A, Chaurasia A Heliyon. 2024; 10(10):e31061.

PMID: 38813162 PMC: 11133762. DOI: 10.1016/j.heliyon.2024.e31061.


References
1.
Myers J, Greenberg J, Mo V, Roberts D . Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 2001; 92(12):3030-6. DOI: 10.1002/1097-0142(20011215)92:12<3030::aid-cncr10148>3.0.co;2-p. View

2.
DSouza G, Kreimer A, Viscidi R, Pawlita M, Fakhry C, Koch W . Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356(19):1944-56. DOI: 10.1056/NEJMoa065497. View

3.
Gourin C, Johnson J . Incidence of unsuspected metastases in lateral cervical cysts. Laryngoscope. 2000; 110(10 Pt 1):1637-41. DOI: 10.1097/00005537-200010000-00012. View

4.
Chaturvedi A, Engels E, Anderson W, Gillison M . Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26(4):612-9. DOI: 10.1200/JCO.2007.14.1713. View

5.
Carvalho A, Nishimoto I, Califano J, Kowalski L . Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2004; 114(5):806-16. DOI: 10.1002/ijc.20740. View